Tikosyn is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Avera Mckennan Hospital. The primary component is Dofetilide.
Product ID | 69189-5820_7c329776-808b-4c94-a77b-3c0d403917b6 |
NDC | 69189-5820 |
Product Type | Human Prescription Drug |
Proprietary Name | Tikosyn |
Generic Name | Dofetilide |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2016-03-28 |
Marketing Category | NDA / NDA |
Application Number | NDA020931 |
Labeler Name | Avera McKennan Hospital |
Substance Name | DOFETILIDE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Antiarrhythmic [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2016-03-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020931 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-03-28 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
DOFETILIDE | .5 mg/1 |
SPL SET ID: | b77b4388-36ec-4971-90a5-353879adb8b5 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0069-5800 | Tikosyn | dofetilide |
0069-5810 | Tikosyn | dofetilide |
0069-5820 | Tikosyn | dofetilide |
69189-5800 | Tikosyn | Tikosyn |
69189-5810 | Tikosyn | Tikosyn |
69189-5820 | Tikosyn | Tikosyn |
0904-6681 | Dofetilide | Dofetilide |
0904-6682 | Dofetilide | Dofetilide |
0904-6683 | Dofetilide | Dofetilide |
16714-840 | Dofetilide | Dofetilide |
16714-841 | Dofetilide | Dofetilide |
16714-842 | Dofetilide | Dofetilide |
16729-490 | Dofetilide | Dofetilide |
16729-491 | Dofetilide | Dofetilide |
16729-492 | Dofetilide | Dofetilide |
42291-411 | Dofetilide | Dofetilide |
42291-412 | Dofetilide | Dofetilide |
42291-413 | Dofetilide | Dofetilide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TIKOSYN 75320488 2375648 Live/Registered |
Pfizer Inc. 1997-07-07 |